APA (7th ed.) Citation

Chen, R., Guan, X., Hu, P., Dong, Y., Zhu, Y., Zhang, T., . . . Zhang, S. (2022). First-In-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, a Small-Molecule Factor XIa Inhibitor in Healthy Subjects. Frontiers in pharmacology, 13, 821363. https://doi.org/10.3389/fphar.2022.821363

Chicago Style (17th ed.) Citation

Chen, Rui, Xiaoduo Guan, Pei Hu, Yanli Dong, Yi Zhu, Tengfei Zhang, Jianjun Zou, and Shuyang Zhang. "First-In-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, a Small-Molecule Factor XIa Inhibitor in Healthy Subjects." Frontiers in Pharmacology 13 (2022): 821363. https://doi.org/10.3389/fphar.2022.821363.

MLA (9th ed.) Citation

Chen, Rui, et al. "First-In-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, a Small-Molecule Factor XIa Inhibitor in Healthy Subjects." Frontiers in Pharmacology, vol. 13, 2022, p. 821363, https://doi.org/10.3389/fphar.2022.821363.